Yap CS - Search Results

1

FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?

Yap CS, Schiepers C, Fishbein MC, Phelps ME, Czernin J. Yap CS, et al. Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1166-73. doi: 10.1007/s00259-002-0853-y. Epub 2002 Jun 4. Eur J Nucl Med Mol Imaging. 2002. PMID: 12192561

2

Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation.

Filmont JE, Czernin J, Yap C, Silverman DH, Quon A, Phelps ME, Emmanouilides C. Filmont JE, et al. Chest. 2003 Aug;124(2):608-13. doi: 10.1378/chest.124.2.608. Chest. 2003. PMID: 12907550

3

The impact of PET on the management of lung cancer: the referring physician's perspective.

Seltzer MA, Yap CS, Silverman DH, Meta J, Schiepers C, Phelps ME, Gambhir SS, Rao J, Valk PE, Czernin J. Seltzer MA, et al. Among authors: yap cs. J Nucl Med. 2002 Jun;43(6):752-6. J Nucl Med. 2002. PMID: 12050318 Free article.

4

Cardiac pacemakers and central venous lines can induce focal artifacts on CT-corrected PET images.

Halpern BS, Dahlbom M, Waldherr C, Yap CS, Schiepers C, Silverman DH, Ratib O, Czernin J. Halpern BS, et al. Among authors: yap cs. J Nucl Med. 2004 Feb;45(2):290-3. J Nucl Med. 2004. PMID: 14960650 Free article.

5

Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's disease.

Filmont JE, Yap CS, Ko F, Vranjesevic D, Quon A, Margolis DJ, Safaei A, Emmanouilides C, Silverman DH, Phelps ME, Czernin J. Filmont JE, et al. Among authors: yap cs. Mol Imaging Biol. 2004 Jan-Feb;6(1):47-54. doi: 10.1016/S1536-1632(03)00107-0. Mol Imaging Biol. 2004. PMID: 15018828

6

Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.

Yap CS, Czernin J, Fishbein MC, Cameron RB, Schiepers C, Phelps ME, Weber WA. Yap CS, et al. Chest. 2006 Feb;129(2):393-401. doi: 10.1378/chest.129.2.393. Chest. 2006. PMID: 16478857

7

Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective.

Yap CS, Seltzer MA, Schiepers C, Gambhir SS, Rao J, Phelps ME, Valk PE, Czernin J. Yap CS, et al. J Nucl Med. 2001 Sep;42(9):1334-7. J Nucl Med. 2001. PMID: 11535721 Free article.

8

Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma.

Schöder H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, Valk PE, Sayre J, Czernin J. Schöder H, et al. J Nucl Med. 2001 Aug;42(8):1139-43. J Nucl Med. 2001. PMID: 11483671 Free article. Clinical Trial.

9

Indirect monitoring of endogenous gene expression by positron emission tomography (PET) imaging of reporter gene expression in transgenic mice.

Green LA, Yap CS, Nguyen K, Barrio JR, Namavari M, Satyamurthy N, Phelps ME, Sandgren EP, Herschman HR, Gambhir SS. Green LA, et al. Among authors: yap cs. Mol Imaging Biol. 2002 Jan;4(1):71-81. doi: 10.1016/s1095-0397(01)00071-1. Mol Imaging Biol. 2002. PMID: 14538050

10

Facing death alone: An exploration of terminally ill individuals living alone in palliative care.

Bashyam P, Yap CS, Chen X, Yeo ZZ. Bashyam P, et al. Among authors: yap cs. Ann Acad Med Singap. 2024 Sep 27;53(9):588-590. doi: 10.47102/annals-acadmedsg.2023426. Ann Acad Med Singap. 2024. PMID: 39373379 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters